VVG Health Limited 11143387 false 2025-03-01 2026-02-28 2026-02-28 The principal activity of the company is the provision of veterinary services. Digita Accounts Production Advanced 6.30.9574.0 true true 11143387 2025-03-01 2026-02-28 11143387 2026-02-28 11143387 bus:Director2 1 2026-02-28 11143387 core:AcceleratedTaxDepreciationDeferredTax 2026-02-28 11143387 core:RetainedEarningsAccumulatedLosses 2026-02-28 11143387 core:CurrentFinancialInstruments 2026-02-28 11143387 core:CurrentFinancialInstruments core:WithinOneYear 2026-02-28 11143387 core:Non-currentFinancialInstruments 2026-02-28 11143387 core:Non-currentFinancialInstruments core:AfterOneYear 2026-02-28 11143387 core:Goodwill 2026-02-28 11143387 core:BetweenTwoFiveYears 2026-02-28 11143387 core:MoreThanFiveYears 2026-02-28 11143387 core:WithinOneYear 2026-02-28 11143387 core:ConstructionInProgressAssetsUnderConstruction 2026-02-28 11143387 core:FurnitureFittingsToolsEquipment 2026-02-28 11143387 core:MotorVehicles 2026-02-28 11143387 core:OtherPropertyPlantEquipment 2026-02-28 11143387 bus:SmallEntities 2025-03-01 2026-02-28 11143387 bus:AuditExemptWithAccountantsReport 2025-03-01 2026-02-28 11143387 bus:FilletedAccounts 2025-03-01 2026-02-28 11143387 bus:SmallCompaniesRegimeForAccounts 2025-03-01 2026-02-28 11143387 bus:RegisteredOffice 2025-03-01 2026-02-28 11143387 bus:Director1 2025-03-01 2026-02-28 11143387 bus:Director2 2025-03-01 2026-02-28 11143387 bus:Director2 1 2025-03-01 2026-02-28 11143387 bus:PrivateLimitedCompanyLtd 2025-03-01 2026-02-28 11143387 bus:Agent1 2025-03-01 2026-02-28 11143387 core:Goodwill 2025-03-01 2026-02-28 11143387 core:ConstructionInProgressAssetsUnderConstruction 2025-03-01 2026-02-28 11143387 core:FurnitureFittings 2025-03-01 2026-02-28 11143387 core:FurnitureFittingsToolsEquipment 2025-03-01 2026-02-28 11143387 core:MotorVehicles 2025-03-01 2026-02-28 11143387 core:OfficeEquipment 2025-03-01 2026-02-28 11143387 core:OtherPropertyPlantEquipment 2025-03-01 2026-02-28 11143387 core:PlantMachinery 2025-03-01 2026-02-28 11143387 countries:EnglandWales 2025-03-01 2026-02-28 11143387 2025-02-28 11143387 bus:Director2 1 2025-02-28 11143387 core:Goodwill 2025-02-28 11143387 core:ConstructionInProgressAssetsUnderConstruction 2025-02-28 11143387 core:FurnitureFittingsToolsEquipment 2025-02-28 11143387 core:MotorVehicles 2025-02-28 11143387 core:OtherPropertyPlantEquipment 2025-02-28 11143387 2024-03-01 2025-02-28 11143387 2025-02-28 11143387 bus:Director2 1 2025-02-28 11143387 core:AcceleratedTaxDepreciationDeferredTax 2025-02-28 11143387 core:CurrentFinancialInstruments 2025-02-28 11143387 core:CurrentFinancialInstruments core:WithinOneYear 2025-02-28 11143387 core:Non-currentFinancialInstruments 2025-02-28 11143387 core:Non-currentFinancialInstruments core:AfterOneYear 2025-02-28 11143387 core:Goodwill 2025-02-28 11143387 core:BetweenTwoFiveYears 2025-02-28 11143387 core:MoreThanFiveYears 2025-02-28 11143387 core:WithinOneYear 2025-02-28 11143387 core:ConstructionInProgressAssetsUnderConstruction 2025-02-28 11143387 core:FurnitureFittingsToolsEquipment 2025-02-28 11143387 core:MotorVehicles 2025-02-28 11143387 core:OtherPropertyPlantEquipment 2025-02-28 11143387 bus:Director2 1 2024-03-01 2025-02-28 11143387 bus:Director2 1 2024-02-29 iso4217:GBP xbrli:pure

Registration number: 11143387

Prepared for the registrar

VVG Health Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 28 February 2026

 

VVG Health Limited

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 13

 

VVG Health Limited

Company Information

Directors

E Dawes

S J D Dawes

Registered office

Valley Veterinary Group
Tutts Clump
Bradfield
Reading
RG7 6JU

Accountants

Hazlewoods LLP Staverton Court
Staverton
Cheltenham
GL51 0UX

 

VVG Health Limited

(Registration number: 11143387)
Balance Sheet as at 28 February 2026

Note

2026
£

2025
£

Fixed assets

 

Intangible assets

4

824,536

893,246

Tangible assets

5

27,738

30,131

 

852,274

923,377

Current assets

 

Stocks

45,364

41,079

Debtors

6

35,509

52,386

Cash at bank and in hand

 

268,326

191,385

 

349,199

284,850

Creditors: Amounts falling due within one year

7

(347,080)

(279,102)

Net current assets

 

2,119

5,748

Total assets less current liabilities

 

854,393

929,125

Creditors: Amounts falling due after more than one year

7

(344,991)

(390,688)

Deferred tax liabilities

8

(6,834)

(7,477)

Net assets

 

502,568

530,960

Capital and reserves

 

Called up share capital

10

8

8

Retained earnings

502,560

530,952

Shareholders' funds

 

502,568

530,960

For the financial year ending 28 February 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

 

VVG Health Limited

(Registration number: 11143387)
Balance Sheet as at 28 February 2026

Approved and authorised by the Board on 27 July 2026 and signed on its behalf by:
 


E Dawes
Director


S J D Dawes
Director

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

 

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Valley Veterinary Group
Tutts Clump
Bradfield
Reading
RG7 6JU
United Kingdom

 

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except for, where disclosed in these accounting policies, certain items that are shown at fair value.

The presentational currency of the financial statements is Pounds Sterling, being the functional currency of the primary economic environment in which the company operates. Monetary amounts in these financial statements are rounded to the nearest Pound.

Going concern

After reviewing the company's current forecasts and projections, together with the facilities available to the company, the director has a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

Critical accounting judgements and key sources of estimation uncertainty
In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
 

Judgements

No significant judgements have been made by management in preparing these financial statements.

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

Key sources of estimation uncertainty

No key sources of estimation uncertainty have been identified by management in preparing these financial statements other than those detailed in these accounting policies.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in the profit and loss account, except that a charge attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts in the financial statements and on unused tax losses or tax credits in the company. Deferred income tax is determined using tax rates and laws that have been enacted or substantively enacted by the reporting date.

The carrying amount of deferred tax assets are reviewed at each reporting date and a valuation allowance is set up against deferred tax assets so that the net carrying amount equals the highest amount that is more likely than not to be recovered based on current or future taxable profit.

Tangible assets

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% of written down value

Fixtures and fittings

25% of written down value

Motor vehicles

25% of written down value

Office equipment

25% of written down value

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

Intangible assets

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Goodwill

20 years straight line

Investments

Investments in equity shares which are publicly traded or where the fair value can be measured reliably are initially measured at fair value, with changes in fair value recognised in profit or loss. Investments in equity shares which are not publicly traded and where fair value cannot be measured reliably are measured at cost less impairment.

Interest income on debt securities, where applicable, is recognised in income using the effective interest method. Dividends on equity securities are recognised in income when receivable.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. All trade debtors are repayable within one year and hence are included at the undiscounted cost of cash expected to be received. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the debtors.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and all are repayable within one year and hence are included at the undiscounted amount of cash expected to be paid.

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Leases

Leases in which substantially all the risks and rewards of ownership are retained by the lessor are classified as operating leases. Payments made under operating leases are charged to profit or loss on a straight-line basis over the period of the lease.

Share capital

Ordinary shares are classified as equity, equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. if payment is deferred and the time value of money is material, the initail measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.

 Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.

 Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

Financial instruments


Classification
Financial instruments are classified and accounted for according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability on the balance sheet. The corresponding dividends relating to the liability component are charged as interest expenses in the profit and loss account.


Recognition and measurement
All financial assets and liabilities are initially measured at transaction price (including transaction costs), except for those financial assets classified as at fair value through profit or loss, which are initially measured at fair value (which is normally the transaction price excluding transaction costs), unless the arrangement constitutes a financing transaction. If an arrangement constitutes a financing transaction, the financial asset or financial liability is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.


Impairment
Assets, other than those measured at fair value, are assessed for indicators of impairment at each balance sheet date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss as described below.

A non financial asset is impaired where there is objective evidence that, as a result of one or more events that occurred after initial recognition, the estimated recoverable value of the asset has been reduced. The recoverable amount of an asset is the higher of its fair value less costs to sell and its value in use.

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

 

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was as follows:

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

 

5

Tangible assets

Plant and machinery
 £

Fixtures and fittings
 £

Office equipment
 £

Motor vehicles
 £

Total
£

Cost

At 1 March 2025

55,960

15,660

5,575

437

77,632

Additions

1,547

3,890

-

-

5,437

At 28 February 2026

57,507

19,550

5,575

437

83,069

Depreciation

At 1 March 2025

37,770

5,043

4,309

379

47,501

Charge for the year

3,869

3,774

172

15

7,830

At 28 February 2026

41,639

8,817

4,481

394

55,331

Carrying amount

At 28 February 2026

15,868

10,733

1,094

43

27,738

At 28 February 2025

18,190

10,617

1,266

58

30,131

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

 

6

Debtors

2026
£

2025
£

Trade debtors

23,115

30,024

Prepayments

9,445

8,093

Other debtors

2,949

14,269

35,509

52,386

 

7

Creditors

Note

2026
£

2025
£

Due within one year

 

Loans and borrowings

9

67,981

50,884

Trade creditors

 

39,945

45,158

Taxation and social security

 

224,497

169,524

Accruals and deferred income

 

12,330

11,632

Other creditors

 

2,327

1,904

 

347,080

279,102

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

 

8

Deferred tax

Deferred tax assets and liabilities

2026

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

6,834

6,834

2025

Liability
£

Difference between accumulated depreciation and amortisation and capital allowances

7,477

7,477

 

9

Loans and borrowings

Current loans and borrowings

2026
£

2025
£

Bank borrowings

47,551

50,884

Other borrowings

20,430

-

67,981

50,884

Non-current loans and borrowings

2026
£

2025
£

Bank borrowings

344,991

390,688

 

VVG Health Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2026

 

10

Share capital

Allotted, called up and fully paid shares

 

2026

2025

 

No.

£

No.

£

Ordinary A of £0.01 each

408

4.08

408

4.08

Ordinary B of £0.01 each

392

3.92

392

3.92

Ordinary C of £0.01 each

1

0.01

1

0.01

 

801

8

801

8

The different classes of shares referred to above carry separate rights to dividends, but in all other significant respects rank pari passu, other than the Ordinary C share which has no voting rights and a defined right to participate in a distribution of assets upon a winding up.

 

11

Financial commitments

Operating leases

The total of future minimum lease payments is as follows:

2026
 £

2025
 £

Not later than one year

120,352

120,352

Later than one year and not later than five years

481,408

481,408

Later than five years

344,804

465,156

946,564

1,066,916

The amount of non-cancellable operating lease payments recognised as an expense during the year was £120,352 (2025 - £120,352).

 

12

Related party transactions

At the year end, the company owed the directors £20,430 (2025: £7,525 owed by the directors to the company). This amount is included within other borrowings (2025: other debtors). There are no fixed repayment terms and no interest is charged.

Transactions with directors

2026

At 1 March 2025
£

Advances to director
£

Repayments by director
£

At 28 February 2026
£

S J D Dawes

Amounts due to / (from) director

(7,525)

(312,045)

340,000

20,430

2025

At 1 March 2024
£

Advances to director
£

Repayments by director
£

At 28 February 2025
£

S J D Dawes

Amounts due to / (from) director

33,514

(401,039)

360,000

(7,525)